<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 149 - Mims</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page148.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../index.html#p=149">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 149 - Mims</div>
        <div id="content-top2">P. 149</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../index.html#p=149"><img src="../thumb/149.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Drug-class overview         35



                                                     v
          or thrombo-embolism  local reactions and skin     enous thrombosis prophylaxis in medicated
          necrosis  anaphylactic reaction  Cutaneous or   patients
          systemic allergic reactions   Hepatitis    blood        40 mg daily subcutaneously, continue for a
          dyscrasias  no intramuscular injections     minimum of 6 days and continue until fully
          Special precautions: 20                      ambulatory or a maximum of 14 days
                                                     d
          Failed therapy and consequent clot formation     eep vein thrombosis treatment
                                                       1
          and obstruction reports in presence of prosthetic         mg/kg  12-hourly  subcutaneously.
          heart valves    When neuraxial anaesthesia or   Continue until a therapeutic anticoagulant   Drug-class overview
          spinal  puncture  employed,  high  risks  involved;   effect  is  achieved.  treatment  is  usually
          monitor for signs and symptoms of neurological   continued  for 5-10  days and  initiate oral
          impairment  frequently    Considerer  risk-to-  anticoagulation therapy when appropriate
                                                     P
                                                      r
          benefit ratio before neuraxial intervention in     evention of extracorporeal thrombus
          anticoagulated thromboprophylaxis patients   during haemodialysis
            rapidly developing and severe throm-       1 mg/kg.  reduce dose to 0.5 mg/kg in
          bocytopenia    thrombocytopenia   Platelet   patients with high risk of haemorrhage
          defects    Severe  hepatic  or  renal  insufficiency   for double vascular access or 0.75 mg/kg
                                                       for singular vascular access. Introduce into
            uncontrolled hypertension   Hypertensive   arterial line of the circuit at beginning of
          or diabetic retinopathy   High doses in newly   session for a 4-hour session. a further dose
          operated patients   Prolongation of aPtt may   of 0.5-1 mg/kg, if necessary
          lead to overdose   Monitor anti-Xa level with   Contraindications: 20
          haemodialysis   Increased bleeding risk in   Heparin, heparin derivative or low-molecular-
          coronary artery disease and MI patients  Possible   weight  heparins  hypersensitivity    Heparin
          toxicity for premature infants after benzyl alcohol   associated with thrombocytopenia    acute
          administration  elderly                bleeding   Patients at risk of haemorrhage,
          Drug interactions: 20                   including peptic ulcer  Haemorrhagic bleeding
          agents that may affect haemostasis      disorders  thrombocytopenia  Cerebrovascular
                                                  disorders   Infective endocarditis and severe
          enoxaparin                              or  uncontrolled  hypertension    Pregnancy and
          Indications:                            lactation   Children    venous thrombosis and
                   20
          Prevention of post-operative venous thrombo-  embolism treatment at home  Prosthetic heart
          embolism and embolism in high- and moderate-  valves
          risk patients    venous  thrombo-embolism   Side effects: 20
          prophylaxis in bedridden patients  treatment of   bleeding in the presence of associated risk factors
          deep vein thrombosis  Prevention of ischaemic    Fatal retroperitoneal and intra-cranial bleeding
          complications of unstable angina or non-Q-wave    Intraspinal haematoma with concurrent
          MI within 24 hours of onset  Prevent thrombus   anticoagulant use and spinal or epidural
          formation  in extracorporeal  circulation during   anaesthesia  risk of haematoma is increased with
          haemodialysis                           high-dosage regimens, post-operative epidural
          Dosage: 20                              indwelling  catheter  or concomitant  agents
                                                  affecting haemostasis  thrombocytopenia with
             P
            ost-operative venous thrombo-embolism   or without arterial thrombosis    local reactions
             and embolism prophylaxis              Cutaneous or systemic allergic reactions
               igh-risk orthopaedic surgery: 40 mg daily    Hepatitis  blood dyscrasias  no intramuscular
               H
               subcutaneously  with first injection 12   injections
               hours pre-operatively. Continue for 7-10   Special precautions: 20
               days after surgery or as long as patient is   Failed therapy and consequent clot formation
               not ambulatory. Continue with 40 mg daily   and obstruction reports in presence of prosthetic
               for 3 weeks in total hip replacement  heart valves    neuraxial technique should be
               oderate-risk general surgery: 20 mg daily   avoided during administration of pre-operative
               M
               subcutaneously with first injection 2 hours   dose    delay placement or removal of catheter
               pre-operatively. Continue for 7-10 days   for 10-12 hours after deep vein thrombosis
               after surgery or as long as patient is not   prophylaxis administration  delay placement or
               ambulatory                         removal of catheter for 24 hours after deep vein


                     MIMS ConCISe GuIde to CardIovaSCular, MetabolIC and endoCrIne dISeaSeS  VOLUME 1</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page148.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page144.html">144</a>&nbsp;&nbsp;&nbsp;<a href="page145.html">145</a>&nbsp;&nbsp;&nbsp;<a href="page146.html">146</a>&nbsp;&nbsp;&nbsp;<a href="page147.html">147</a>&nbsp;&nbsp;&nbsp;<a href="page148.html">148</a>&nbsp;&nbsp;&nbsp;<a href="page149.html">149</a>&nbsp;&nbsp;&nbsp;<a href="page150.html">150</a>&nbsp;&nbsp;&nbsp;<a href="page151.html">151</a>&nbsp;&nbsp;&nbsp;<a href="page152.html">152</a>&nbsp;&nbsp;&nbsp;<a href="page153.html">153</a>&nbsp;&nbsp;&nbsp;<a href="page154.html">154</a>
             </td>
             <td width="35%"><a href="page150.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page150.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
